Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current


Salarius Pharmaceuticals: Q2 Earnings Insights

Author: Benzinga Insights | August 05, 2022 05:26pm

Salarius Pharmaceuticals (NASDAQ:SLRX) reported its Q2 earnings results on Friday, August 5, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.


Salarius Pharmaceuticals beat estimated earnings by 10.0%, reporting an EPS of $-0.09 versus an estimate of $-0.1.

Revenue was down $571 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 15.36% drop in the share price the next day.


To track all earnings releases for Salarius Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: SLRX